Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print RSS Feed

India Report

3 (d): The Third Dimension
S. Harachand, Contributing Editor
May 6, 2013
Limit the verdict to Glivec  Read More »
Active & Non-Active Deals
S. Harachand, Contributing Editor
April 3, 2013
APIs behind big buys   Read More »
Call for Cleaner CROs
S. Harachand, Contributing Editor
March 6, 2013
Law turns tough on the errants  Read More »
Spotlight on Steriles
S. Harachand, Contributing Editor
January 22, 2013
Injectables steal the show  Read More »
Offshoring Research
S. Harachand, Contributing Editor
November 9, 2012
Discovery outsourcing bounces back  Read More »
Active Third Parties
S. Harachand, Contributing Editor
October 11, 2012
Have CMOs gained the edge over captives?  Read More »
Trials on Trial
S. Harachand, Contributing Editor
September 6, 2012
CROs to face stricter vigilance   Read More »
(Bio)Similar Deals
S. Harachand, Contributing Editor
July 18, 2012
New models emerge in biogenerics sourcing  Read More »
CROs Turn Proactive
S. Harachand, Contributing Editor
May 30, 2012
Online tool to clean up errants  Read More »
Discovering Discovery?
S. Harachand, Contributing Editor
May 4, 2012
CMOs get spirited on discovery models  Read More »
Move To Monoclonals
S Harachand
April 4, 2012
CMOs' MAb skills in the spotlight  Read More »
On the API Trail
S. Harachand, Contributing Editor
March 7, 2012
Expansions, exits and much more  Read More »
A Clinical Act
S. Harachand
January 23, 2012
A regulator emerges as savior  Read More »
CEOs Make The Sojourn
S. Harachand
November 14, 2011
Multinationals get bullish about India  Read More »
A Decisive Market For Device Makers
S. Harachand
October 11, 2011
Tie-ups can cut costs  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On
Please visit our sister sites: